Research progress on immune tolerance after liver transplantation
-
摘要: 肝移植是目前公认的治疗终末期肝病的最有效措施,而如何让移植受者获得免疫耐受状态则是肝移植科医师追求的最终目标。了解最新的国际多中心临床经验以及相关基础研究结果,有助于我们更深入地认识免疫耐受,从而为移植受者制定更加妥善的治疗方案。本文综合国际核心期刊报道的内容,从临床免疫耐受的可行性、免疫耐受的诱导和维持、免疫耐受诱导方案的制定及寻找合理的免疫状态的相关监测指标等方面作一综述,并对今后的研究方向作出展望。
-
[1] DEVLIN J, DOHERTY D, THOMSON L, et al. Defining the outcome of immunosuppression withdrawal after liver transplantation[J]. Hepatology, 1998, 27(4):926-933. doi: 10.1002/(ISSN)1527-3350 [2] FENG S, EKONG UD, LOBRITTO SJ, et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants[J]. JAMA, 2012, 307(3):283-293. DOI: 10.1001/jama.2011.2014. [3] DE LA GARZA RG, SAROBE P, MERINO J, et al. Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance[J]. Liver Transpl, 2013, 19(9):937-944. DOI: 10.1002/lt.23686. [4] BRANCO JC, MORBEY A, MARTINS A, et al. Tolerance after liver transplantation: where are we?[J]. Liver Transpl, 2018, 24(9):1303-1304. DOI: 10.1002/lt.25294. [5] DEMETRIS AJ, BELLAMY CO, GANDHI CR, et al.Functional immune anatomy of the liver-as an allograft[J]. Am J Transplant, 2016, 16(6):1653-1680. DOI: 10.1111/ajt.13749. [6] NEUMANN K, RUDOLPH C, NEUMANN C, et al. Liver sinusoidal endothelial cells induce immunosuppressive IL-10-producing Th1 cells via the Notch pathway[J]. Eur J Immunol, 2015, 45(7):2008-2016. DOI: 10.1002/eji.201445346. [7] CHEN Y, XIE C, ZHENG X, et al. LIN28/let-7/PD-L1 pathway as a target for cancer immunotherapy[J]. Cancer Immunol Res, 2019, 7(3):487-497. DOI: 10.1158/2326-6066.CIR-18-0331. [8] KARIMI MH, GERAMIZADEH B, MALEK-HOSSEINI SA. Tolerance induction in liver[J]. Int J Organ Transplant Med, 2015, 6(2):45-54. doi: 10.1016-S1091-255X(02)00012-4/ [9] LI L, WOZNIAK LJ, RODDER S, et al. A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation[J]. Am J Transplant, 2012, 12(5):1218-1228. DOI: 10.1111/j.1600-6143.2011.03928.x. [10] HIGASHI T, FRIEDMAN SL, HOSHIDA Y. Hepatic stellate cells as key target in liver fibrosis[J]. Adv Drug Deliv Rev, 2017, 121:27-42. DOI: 10.1016/j.addr.2017.05.007. [11] THOMSON AW, EZZELARAB MB. Regulatory dendritic cells: profiling, targeting, and therapeutic application[J]. Curr Opin Organ Transplant, 2018, 23(5):538-545. DOI: 10.1097/MOT.0000000000000565. [12] MUCKSOVÁ J, PLACHÝ J, STANĚK O, et al. Cytokine response to the RSV antigen delivered by dendritic cell-directed vaccination in congenic chicken lines[J]. Vet Res, 2017, 48(1):18. DOI: 10.1186/s13567-017-0423-8. [13] LOTT DG, DAN O, LU L, et al. Decoy NF-kappaB fortified immature dendritic cells maintain laryngeal allograft integrity and provide enhancement of regulatory T cells[J]. Laryngoscope, 2010, 120(1):44-52. DOI: 10.1002/lary.20667. [14] CHATURVEDI V, COLLISON LW, GUY CS, et al. Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance[J]. J Immunol, 2011, 186(12):6661-6666. DOI: 10.4049/jimmunol.1100315. [15] KNIGHT SR, MORRIS PJ. Steroid sparing protocols following nonrenal transplants; the evidence is not there. a systematic review and Meta-analysis[J]. Transpl Int, 2011, 24(12):1198-1207. DOI: 10.1111/j.1432-2277.2011.01335.x. [16] European Association for the Study of the Liver. EASL clinical practice guidelines: liver transplantation[J]. J Hepatol, 2016, 64(2):433-485. DOI: 10.1016/j.jhep.2015.10.006. [17] THIERRY A, LE MEUR Y, ECOTIÈRE L, et al. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study[J]. Transpl Int, 2016, 29(1):23-33. DOI: 10.1111/tri.12627. [18] YARYGIN KN, LUPATOV AY, SUKHIKH GT. Modulation of immune responses by mesenchymal stromal cells[J]. Bull Exp Biol Med, 2016, 161(4):561-565. DOI: 10.1007/s10517-016-3461-8. [19] LI XL, MÉNORET S, BEZIE S, et al. Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance[J]. J Immunol, 2010, 185(2):823-833. DOI: 10.4049/jimmunol.1000120. [20] TODO S, YAMASHITA K, GOTO R, et al. A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation[J]. Hepatology, 2016, 64(2):632-643. DOI: 10.1002/hep.8459. [21] ALEXOPOULOS SP, NEKRASOV V, CAO S, et al. Effects of recipient size and allograft type on pediatric liver transplantation for biliary atresia[J]. Liver Transpl, 2017, 23(2):221-233. DOI: 10.1002/lt.24675. [22] RUIZ P, MARTÍNEZ-PICOLA M, SANTANA M, et al. Torque teno virus is associated with the state of immune suppression early after liver transplantation[J]. Liver Transpl, 2019, 25(2):302-310. DOI: 10.1002/lt.25374. [23] RODRIGO E, LÓPEZ-HOYOS M, CORRAL M, et al. ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and Meta-analysis[J]. Liver Transpl, 2012, 18(10):1245-1253. DOI: 10.1002/lt.23497.
点击查看大图
计量
- 文章访问数: 326
- HTML全文浏览量: 101
- PDF下载量: 37
- 被引次数: 0